中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Discovery of a novel inhibitor of NAD(P)(+)-dependent malic enzyme (ME2) by high-throughput screening

文献类型:期刊论文

作者Wen, Yi1; Xu, Lei2; Chen, Fang-lei2; Gao, Jing1; Li, Jing-ya2; Hu, Li-hong2; Li, Jia2
刊名ACTA PHARMACOLOGICA SINICA
出版日期2014-05
卷号35期号:5页码:674-684
关键词malic enzyme ME2 inhibitor natural product NPD389 high-throughput screening structure-activity relationship enzyme kinetics thermal shift assay
ISSN号1671-4083
DOI10.1038/aps.2013.189
文献子类Article
英文摘要Aim: Malic enzymes are oxidative decarboxylases with NAD(+) or NAD(P)(+) as cofactor that catalyze the conversion of L-malate to pyruvate and CO2. The aim of this study was to discover and characterize a potent inhibitor of human NAD(P)(+)-dependent malic enzyme 2 (ME2). Methods: Recombinant human ME2-His-Tag fusion protein was overexpressed in E coli and purified with Ni-NTA resin. A high-throughput screening (HTS) assay was developed to find ME2 inhibitors. Detergent Brij-35 was used to exclude false positives. The characteristics of the inhibitor were analyzed with enzyme kinetics analysis. A thermal shift assay for ME2 was carried out to verify the binding of the inhibitor with the enzyme. Results: An HTS system for discovering ME2 inhibitors was established with a Z' factor value of 0.775 and a signal-to-noise ratio (S/N) of 9.80. A library containing 12 683 natural products was screened. From 47 hits, NPD387 was identified as an inhibitor of ME2. The primary structure-activity relationship study on NPD387 derivatives showed that one derivative NPD389 was more potent than the parent compound NPD387 (the IC50 of NPD389 was 4.63 +/- 0.36 mu mol/L or 5.59 +/- 0.38 mu mol/L, respectively, in the absence or presence of 0.01% Brij-35 in the assay system). The enzyme kinetics analysis showed that NPD389 was a fast-binding uncompetitive inhibitor with respect to the substrate NAD(+) and a mixed-type inhibitor with respect to the substrate L-malate. Conclusion: NPD389 is a potent ME2 inhibitor that binds to the enzyme in a fast-binding mode, acting as an uncompetitive inhibitor with respect to the substrate NAD(+) and a mixed-type inhibitor with respect to the substrate L-malate.
WOS关键词THERMAL SHIFT ASSAYS ; STATISTICAL PARAMETER ; QUALITY-CONTROL ; DRUG DISCOVERY ; RNAI SCREENS ; PROGRESSION ; MECHANISM ; HIT ; ATP
资助项目National Natural Science Foundation of China[81125023] ; National Natural Science Foundation of China[81021062] ; National Science and Technology Major Projects for Major New Drugs Innovation and Development[2013ZX09507002] ; Shanghai Commission of Science and Technology[11DZ2292200] ; Shanghai Commission of Science and Technology[13DZ2290300]
WOS研究方向Chemistry ; Pharmacology & Pharmacy
语种英语
CSCD记录号CSCD:5142658
WOS记录号WOS:000335447000012
出版者ACTA PHARMACOLOGICA SINICA
源URL[http://119.78.100.183/handle/2S10ELR8/277101]  
专题国家新药筛选中心
中科院受体结构与功能重点实验室
新药研究国家重点实验室
药物安全性评价中心
通讯作者Li, Jia
作者单位1.Jiangsu Univ, Sch Pharm, Zhenjiang 212013, Peoples R China;
2.Chinese Acad Sci, State Key Lab Drug Res, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China
推荐引用方式
GB/T 7714
Wen, Yi,Xu, Lei,Chen, Fang-lei,et al. Discovery of a novel inhibitor of NAD(P)(+)-dependent malic enzyme (ME2) by high-throughput screening[J]. ACTA PHARMACOLOGICA SINICA,2014,35(5):674-684.
APA Wen, Yi.,Xu, Lei.,Chen, Fang-lei.,Gao, Jing.,Li, Jing-ya.,...&Li, Jia.(2014).Discovery of a novel inhibitor of NAD(P)(+)-dependent malic enzyme (ME2) by high-throughput screening.ACTA PHARMACOLOGICA SINICA,35(5),674-684.
MLA Wen, Yi,et al."Discovery of a novel inhibitor of NAD(P)(+)-dependent malic enzyme (ME2) by high-throughput screening".ACTA PHARMACOLOGICA SINICA 35.5(2014):674-684.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。